Related by context. All words. (Click for frequent words.) 87 Digital Mammographic Imaging 76 DMIST 73 Screening Trial 71 Prostate Lung Colorectal 69 ACRIN 69 Prostate Cancer Prevention 67 PLCO 67 number NCT# ClinicalTrials.gov 67 VADT 66 ExTRACT TIMI 66 CALGB 66 Cholesterol Levels SPARCL 66 CARE HF 66 AVERROES 65 retrospective cohort 65 prospective multicentre 65 Carotid Revascularization Endarterectomy vs. 65 CHAMPION PCI 65 Trial NLST 65 undergone radical prostatectomy 65 ACUITY trial 65 CaPSURE 65 ELCAP 65 BARI 2D 65 Health Initiative Observational 64 prospective longitudinal 64 BRIM3 64 ToGA 64 Aggressive Reduction 64 FDG-PET/CT 64 Ovarian PLCO Cancer 64 PLCO trial 64 Clinical Antipsychotic Trials 64 ovarian endometrial 64 positron emission tomography scans 64 Swedish Mammography Cohort 64 Group RTOG 64 Netherlands Cohort Study 63 BCIRG 63 Intervention Trial GAIT 63 Evaluation WISE 63 endometriosis ovarian cysts 63 ONTARGET 63 retrospective cohort study 63 ENDEAVOR IV 63 ENESTnd 63 Edge STudy 63 multicenter randomized controlled 63 beta carotene supplementation 63 CT colonography CTC 63 Celecoxib APC trial 63 relapsed MM 63 multicenter randomized clinical 63 Subgroup analysis 63 substudy 63 NSABP B 62 CLARITY TIMI 62 Stenting Trial CREST 62 galiximab 62 AVOREN 62 Ovarian Cancer Screening 62 Cervista HPV HR 62 REALITY Trial 62 ISEL 62 Lancet Oncology journal 62 REVIVE Diabetes 62 LHRH receptor positive 62 PERSEUS 62 Multicenter Automatic Defibrillator Implantation 62 #F FDG PET 62 MAGE A3 ASCI 62 prospective multicenter 62 Women Ischemia Syndrome 62 spiral computed tomography 62 prostate cancer CaP 62 STRIDE PD 62 cerebral microbleeds 62 randomized controlled multicenter 62 phase IIIb 62 Automated Breast Ultrasound 62 ongoing Phase IIIb 62 Multicenter AIDS 62 skin sterol 62 prelicensure 62 Registry NOPR 62 BRCA testing 62 transrectal ultrasound guided 62 multicentre prospective 62 FDG PET 62 bazedoxifene conjugated estrogens 62 prospective nonrandomized 62 Gynecologic Oncology Group 62 Breast Specific Gamma 62 Abdominal ultrasound 62 Framingham Offspring 62 Meta analyzes 61 COR Analyzer 61 ROCHESTER Minn. Mayo Clinic 61 Intervention Effectiveness 61 SWOG 61 PRESEPT 61 NLSY 61 RECORD1 61 LungAlert TM 61 virtual colonography 61 BZA CE 61 Colon polyps 61 Faslodex 61 NSABP C 61 prospective observational studies 61 BRIM2 61 MERLIN TIMI 61 Renal Cell Carcinoma RCC 61 advanced adenomas 61 Magnetic resonance 61 Cancer Incidence Mortality 61 Computed Tomographic 61 SEER database 61 CIN2 + 61 NO# [002] 61 Timothy Rebbeck 61 ENDEAVOR III 61 Platinol ® cisplatin 61 Wisconsin Sleep Cohort 61 postmenopausal hormone therapy 61 ZACTIMA 61 BladderChek 61 WHIMS 61 Dr. Kandzari 61 randomized multicenter trial 61 neratinib 61 pancreatic lung 61 CAMMS# 61 Intervention Effectiveness CATIE 61 Sentinel Lymph Node Biopsy 61 ThermoDox ® clinical 61 RE LY trial 61 F FDG PET 61 CHARISMA trial 61 phase IIb study 61 invasive lobular carcinoma 61 Patient Registry 61 conducted retrospective cohort 61 WHEL 61 mammographic density 61 olaparib 61 Bayer HealthCare Onyx Pharmaceuticals 60 APEX PD 60 HPTN 60 prospective observational cohort 60 CAPRIE 60 PROactive study 60 BR.# 60 Phase III AFFIRM 60 PANVAC VF 60 AVADO 60 Adenomas 60 APEX AMI trial 60 Dietary Modification Trial 60 MADIT 60 NSABP 60 computed tomographic 60 RE LY 60 electron beam computed tomography 60 SORT OUT III 60 EUS FNA 60 HORIZONS AMI trial 60 Carotid Stenting 60 Zolinza 60 upper endoscopy 60 Insulin Resistance Atherosclerosis 60 CT Colonography 60 IMPROVE HF 60 Radiation Therapy Oncology 60 pharmacologic stress 60 CT Colonography Trial 60 ADMIRE HF 60 cervical cytology 60 registrational Phase 60 confirmatory clinical 60 LUMINATE 60 Pre RELAX AHF 60 placebo controlled clinical 60 flurpiridaz F 60 UroVysion 60 MGd 60 Histopathological 60 Phase IIIb study 60 EchoCRT 60 advanced adenoma 60 BOLDER II 60 cediranib 60 randomized controlled trials RCTs 60 HER2 positive cancers 60 miRview ™ squamous 60 HCV SPRINT 60 SPIRIT FIRST 60 Neoadjuvant 60 evaluating tivozanib 60 ACOSOG Z# 60 chemoprevention trials 60 OPT CHF 60 Coronary Artery Calcium 60 BUSM researchers 60 nonmetastatic 60 mammographically 60 ABLAVAR ™ 60 Atherosclerosis MESA 60 Advaxis Phase 60 retrospectively analyzed 60 Radiology Imaging Network 60 ACS NSQIP 60 duplex ultrasonography 60 PARTNER Trial 60 Randomized Phase II 60 randomized Phase IIb 60 colonography 60 journal Transfusion 60 Multicenter 60 Alternans 60 deCODE ProstateCancer TM 60 EXPLORE Xa 60 STEP BD 60 RE LY ® 60 selenium supplementation 60 multicenter prospective 60 CARDIA study 60 HYVET 60 Vizilite 60 Hepatocellular Carcinoma HCC 60 bought Glaxo Serevent 60 CALGB # [002] 60 Alpha Tocopherol Beta Carotene 60 deCODE AF TM 60 recurrent glioblastoma multiforme 60 medically inoperable 59 recurrent metastatic 59 invasive lobular 59 atypical hyperplasia 59 finasteride Proscar 59 National Emphysema Treatment 59 Zevalin consolidation 59 FDG PET scans 59 postmenopausal hormones 59 Prostate Cancer ERSPC 59 immunochemical fecal occult 59 Accelerated Partial Breast Irradiation 59 fluorodeoxyglucose positron emission tomography 59 Multiple logistic regression 59 ICON7 59 EBUS FNA 59 Subgroup analyzes 59 brivanib 59 Prospective Randomized 59 AIM HIGH 59 Virtual Colonoscopy 59 fosbretabulin 59 multicenter placebo controlled 59 FDG PET imaging 59 riociguat 59 core needle biopsies 59 inconclusive Pap 59 journal Gynecologic Oncology 59 Radiology Imaging Network ACRIN 59 midstage clinical 59 Val HeFT 59 Lp PLA 2 59 called elastography distinguished 59 abnormal cytology 59 European Randomized Study 59 TRITON TIMI 59 observational cohort study 59 colorectal neoplasms 59 careHPV 59 pivotal bioequivalence 59 undergone hysterectomies 59 Angiographic 59 Prostate Cancer Outcomes 59 Phase IIIB IV 59 Trial PCPT 59 SPARCL 59 densitometry 59 REGARDS 59 advanced neoplasia 59 histologically proven 59 miRview ™ mets 59 EVEREST II 59 EURIDIS 59 ER CHOP 59 Wactawski Wende 59 Lung Cancer Screening 59 TAXUS IV 59 immunochemical 59 Clinical Outcomes Utilizing Revascularization 59 SEER registry 59 colorectal cancer CRC 59 PET CT scanning 59 BRAF mutated 59 genomewide 59 NICE SUGAR 59 landmark ATHENA 59 INTERHEART study 59 SCD HeFT 59 HealthGrades analyzed 59 prospective observational 59 cardiac perfusion 59 pelvic ultrasound 59 longitudinal cohort study 59 TAXUS ARRIVE 59 PLoS ONE journal 59 longitudinal observational study 59 HCV RESPOND 2 59 Arch Surg 59 ClinicalTrials.gov 59 ProstaScint 59 Echocardiographic 59 Menopausal hormone therapy 59 retrospective observational study 59 congenital toxoplasmosis 59 ASCUS 59 #F FDG 59 HER2 expression 59 underwent coronary angiography 59 Septin9 59 immunohistochemical 59 ALLHAT 59 Neuroepidemiology 59 Trandolapril 59 prospectively randomized 59 REVIVE TA 59 PROLARIS 59 quadrivalent HPV vaccine 59 multicenter multinational 59 KRAS gene mutations 59 CONQUER OB 59 PET myocardial perfusion 59 HORIZONS AMI 59 DAPT Study 59 HGPIN 59 Acute Decompensated Heart Failure 59 cardiac magnetic resonance 59 CT Angiography 59 tumor histology 59 colorectal adenoma 59 nonsmall cell lung cancer 59 renal cell carcinomas 58 Arch Neurol 58 PREVENT IV 58 Optical coherence tomography 58 CC genotype 58 Cervista HPV 58 NHANES III 58 recurrent malignant glioma 58 ENGAGE AF TIMI 58 thorough QT 58 Metastatic Prostate Cancer 58 Hepatotoxicity 58 Current Controlled Trials 58 Baltimore Longitudinal Study 58 BMC Musculoskeletal Disorders 58 ORACLE MS 58 Radical prostatectomy 58 anastrazole 58 Multicentre 58 undergoing coronary angiography 58 adjuvant radiotherapy 58 Nymox NX 58 ZOLINZA 58 benign prostatic hyperplasia enlarged 58 PET CT scans 58 Health Initiative WHI 58 malignant polyps 58 Prostate Disease 58 HF ACTION 58 HER2 overexpression 58 conventional cytology 58 Outpatient Setting 58 rALLy trial 58 Ophena 58 nodal metastasis 58 cobas HPV Test 58 differentiated thyroid 58 journal Ophthalmology 58 ASTEROID 58 GLOBOCAN 58 NEVO RES 58 computed tomography angiography 58 EMPHASIS HF trial 58 evaluating mipomersen 58 Study ARIC 58 Raloxifene STAR 58 Group B CALGB 58 papillary renal cell carcinoma 58 MADIT II 58 PERSEUS clinical program 58 metastatic colorectal 58 Coronary CTA 58 bowel capsule endoscopy 58 journal Epilepsia 58 Heterozygous Familial Hypercholesterolemia 58 postmenopausal hormone 58 CLIRS 58 Kaplan Meier analysis 58 Oncotype 58 PCI ExTRACT TIMI 58 Early Lung Cancer 58 Arch Intern Med 58 CARDIA 58 fluvastatin 58 pediatric malignancies 58 GOUT 58 clinico pathological 58 CT perfusion 58 underwent CABG 58 scintigraphic 58 gadobutrol 58 prospective multicenter study 58 USPSTF recommends 58 extracolonic findings 58 Prostate AdenoCarcinoma Treatment 58 Computer Aided Detection 58 Raloxifene Evaluation MORE 58 MEND CABG 58 metastatic HRPC 58 raloxifene Evista 58 Delcath Phase III 58 prostate cancer PCa 58 Virtual colonoscopy 58 MERIT ES 58 Oncotype DX colon cancer 58 RTOG 58 core needle biopsy 58 relapsing remitting MS RRMS 58 Tesmilifene 58 bone scintigraphy 58 Third Eye Retroscope 58 Multicenter Phase 58 Framingham Offspring Study 58 endometrial hyperplasia 58 Corus CAD 58 gefitinib Iressa 58 LibiGel Phase III 58 Dialysis Outcomes 58 Left Ventricular Dysfunction 58 NCCTG N# 58 HPV genotyping 58 adenoma recurrence 58 ADVANCE PD 58 visceral metastases 58 Epigenomics proprietary 58 PLX STROKE targeting 58 antiretroviral naïve 58 Cancer Genetic Markers 58 Colposcopy 58 Tomosynthesis 58 magnetic resonance spectroscopy MRS 58 double blinded randomized 58 Daxor 58 LungSign TM 58 peritoneal cancer 58 PSMA ADC 58 helical CT 58 oral bisphosphonate 58 TAXUS VI 58 electron beam tomography 58 hematopoietic cancers 58 engineered urethras 58 AVAiL 58 Coronary angiography 58 flavopiridol 58 immunohistochemical analysis 58 hormone receptor negative 58 Heart Failure Trial 58 Medidur TM FA 58 journal Resuscitation 58 Diabetes ACCORD 58 kidney urologic 58 intracranial stenosis 58 Diabetes Interventions 58 metastatic HER2 positive 58 HIVNET 58 multicenter Phase III 58 squamous cell lung cancer 58 RIO Lipids 58 NuroPro PD 58 resectable pancreatic cancer 58 MammaPrint R 58 hormone therapy estrogen 58 ILLUSTRATE 58 Stereotactic Body Radiation Therapy 58 phase IIb clinical 58 PRoFESS 58 ductal carcinomas 58 JAMA. 58 liners promos voicetracking 58 pCR 58 florbetaben 58 abdominal ultrasounds 58 Epidemiologic studies 58 DNAwithPap Test 58 Cardiotoxicity 57 chromium supplementation 57 Proellex TM 57 conventional angiography 57 randomized blinded 57 hormone receptor status 57 BEXXAR Therapeutic Regimen 57 Velcade bortezomib 57 Computed tomographic 57 multiple logistic regression 57 Vascugel ® 57 noninvasive outpatient 57 PCPT 57 Naive Patients 57 AIR CF1 57 Ophena TM 57 Xelox 57 budesonide MMX Phase III 57 ABSORB trial 57 neoadjuvant treatment 57 coronary computed tomography 57 MelaFind pivotal 57 TAXUS ATLAS 57 CT angiograms 57 Prolongs Survival 57 prospective randomized multicenter 57 Sipuleucel T 57 Atkins dieters cardiovascular 57 Univariate analysis 57 Kahalalide F 57 CATIE AD 57 soluble CD# ligand 57 malignant mesothelioma Alfacell 57 #rd Annual CTRC 57 multicenter trials 57 pathologic examination 57 Septin 9 57 RX Acculink 57 CIMZIA TM certolizumab pegol 57 underwent surgical resection 57 p# biomarker 57 multicenter clinical trials 57 transvaginal sonography 57 somo • v 57 PROSTVAC VF 57 Contrast Enhanced 57 ACCORD Lipid 57 Complications Trial 57 fecal immunochemical test 57 localized prostate 57 percutaneous cryoablation 57 Prevalence Worldwide 57 blinded randomized placebo controlled 57 cytologic 57 MADIT CRT 57 dutasteride 57 NATRECOR ® 57 cisplatin resistant 57 subclinical atherosclerosis 57 Multi Ethnic Study 57 Thorough QT 57 Gynecological Cancer 57 multicentre randomized 57 histologically confirmed 57 PIB PET 57 DMSc 57 limiting generalizability 57 National Oncologic PET 57 Mayo Clinic Rochester MN 57 iPrEx 57 REACH Registry 57 placebo controlled Phase III 57 APPRAISE 57 APTIMA HPV 57 Spine Patient Outcomes 57 NMP# 57 Depression Study TADS 57 Bowel Project NSABP 57 journal Circulation Cardiovascular 57 pelvic malignancies 57 Prostate Specific Antigen PSA 57 NCT# ClinicalTrials.gov 57 nonrandomized studies 57 prostate ovarian 57 mammographic 57 Randomized Controlled Trials 57 PSA screening 57 ARBITER 6 57 colorectal breast 57 DBMD 57 ovarian pancreatic 57 EDEMA3 57 Gastric Cancer 57 prostate carcinogenesis 57 Observational Study 57 endometrial carcinoma 57 PROSTVAC TM 57 APPROVe 57 observational cohort 57 tibolone 57 ECASS 57 Digene HPV Test 57 colorectal adenomas 57 angiography CCTA 57 conventional coronary angiography 57 Myocet 57 CYT# potent vascular disrupting 57 liver transplant recipients 57 OvaRex MAb 57 abnormal Pap smear 57 GnRH agonists 57 Endovascular Valve Edge 57 journal Menopause 57 Afatinib 57 Enzastaurin 57 multicenter study 57 Demonstrates Sustained 57 EmbraceAC 57 BEZ# 57 dietary questionnaires 57 HER2 positive metastatic breast 57 Hodgkin lymphoma HL 57 International Verapamil SR 57 CYPHER Stent 57 atypical ductal hyperplasia 57 coronary CT angiography 57 sorafenib Nexavar 57 subgroup analyzes 57 Stenting Trial 57 crizotinib PF # 57 BSGI MBI 57 AML MDS 57 HIV HCV coinfected 57 Unstable Angina 57 mertansine 57 ViaDerm hPTH #-# 57 aromatase inhibitors AIs 57 APTIVUS R 57 Rilonacept 57 KIF6 carriers 57 coronary arteriography 57 Phase III metastatic melanoma 57 Randomized Evaluation 57 Mammographic 57 ABCSG 57 preoperative MRI 57 QTinno 57 meta regression 57 bone density measurements 57 multicenter phase 57 membranous nephritis 57 endoscopic ultrasound EUS 57 ASCO GU 57 Coronary Angiography 57 coinfected patients 57 biopsied tissue 57 darbepoetin alpha 57 neuropathologic 57 IL#B 57 NMIBC 57 Invasive Breast Cancer 57 GYTS 57 undergoing radical prostatectomy 57 Phase 1b clinical trials 57 RRMS patients 57 Refractory Angina 57 physicians podiatrists 57 AIR2 Trial 57 Coronary artery calcium 57 Phase III multicenter 57 antibiotic rifaximin 57 lung esophageal 57 CUSTOM II 57 Deforolimus 57 NMP# assay 57 Cervical Pathology 57 dose Iluvien 57 Boston SmartAboutHealth 57 psoriatic arthritis PsA 57 Accessed #/#/# [001] 57 GISSI 57 Histologic 57 trastuzumab emtansine T DM1 57 genomewide association study 57 Darapladib 57 computerized tomography scans 57 DCE MRI 57 Randomized Controlled 57 deCODE BreastCancer 57 Recurrent Breast Cancer 57 stage IIIb IV 57 SIMPADICO 57 Multiethnic Study 57 journal Urology 57 See CLINICAL PHARMACOLOGY 57 Dr. Gabriel Lasala 57 Amrubicin 57 journal CHEST 57 thoracic aortic disease 57 Carotid Endarterectomy 57 Intervention Trial 56 aripiprazole Abilify 56 KRAS status 56 EMPOWER ™ 56 AREDS 56 colorectal cancer incidence 56 Breast conserving 56 metaanalysis 56 J Nutr 56 Clinicaltrials.gov 56 Bucindolol 56 paricalcitol 56 colorectal bowel 56 semistructured interviews 56 Cystoscopy 56 preclinical efficacy 56 Tanespimycin 56 DEB# 56 colon rectal 56 Study HERS 56 KRAS mutation 56 Pap smears mammograms 56 receiving SIMPONI 56 SPIRIT IV 56 Cologuard 56 V3D Colon 56 OVA1 ® 56 Pooled Analysis 56 Screening mammography 56 histologic examination 56 Adenoma Prevention 56 ZD# [001] 56 stratifying patients 56 Common Toxicity Criteria 56 rosuvastatin #mg 56 Phase Ib II 56 multicenter clinical 56 phase IIa clinical 56 Immunohistochemistry 56 Uterine Cancer 56 CAVEATS 56 trastuzumab DM1 T DM1 56 transrectal ultrasound 56 testosterone supplementation 56 Cedars Sinai Maxine Dunitz 56 MTWA testing 56 Acute Coronary Syndromes 56 statin Crestor 56 screening colonoscopies 56 Carotid artery stenting 56 postoperative chemotherapy 56 Long Lesion 56 KIF6 gene variant 56 Meta Analysis 56 Phase 1a clinical 56 singleton pregnancies 56 Thromboembolism 56 Avastin adjuvant 56 nulliparous women 56 dimensional conformal radiotherapy 56 pulmonary angiography 56 abnormal mammograms 56 colon tumors 56 chemotherapy cisplatin 56 Acute Liver Failure 56 cardiac computed tomography 56 solid tumors ZYBRESTAT 56 Pregnancy Registry 56 ezetimibe simvastatin 56 methylation markers 56 CURRENT OASIS 7 56 Oral contraceptive 56 www.cancerconsultants.com 56 MIVI TRUST 56 multicenter Phase II 56 PON1 activity 56 unstable angina UA 56 somatostatin analog 56 EQUIP OB 56 #:#-#,# CrossRef Medline [002] 56 carotid IMT 56 Intravenous immunoglobulin 56 Functional magnetic resonance 56 Serological 56 underwent resection 56 coronary calcification 56 Teriflunomide 56 HER2 amplified 56 Postmenopausal 56 phase Ib 56 spirometric 56 RESIST studies 56 Coronary Artery Bypass Graft 56 Cystatin C 56 intravenous bisphosphonates 56 Cornea Donor Study 56 BRCA deficient 56 catheter angiography 56 rosuvastatin Crestor 56 Glucosamine Chondroitin Arthritis 56 subanalysis 56 coronary calcium 56 Ocular Hypertension Treatment 56 YONDELIS 56 carotid artery stenting 56 TGFBR1 * 6A 56 abdominal computed tomography 56 transabdominal 56 chlamydial infection 56 cervical cancer precursors 56 Randomized Study 56 lipid lowering drugs 56 BMS# 56 multivariable analysis 56 colon polyp 56 randomized discontinuation trial 56 LAB CGRP 56 PRIMO CABG 56 underwent radical prostatectomy 56 Cochrane reviewers 56 Lipid Lowering Treatment 56 Prospective Multicenter 56 Pharmacodynamic 56 Coronary artery calcification 56 SoftScan ® 56 anastrozole Arimidex 56 Randomized trials 56 bone bruise Bettis 56 NATRECOR R 56 Hematological 56 ERSPC 56 serum lipid levels 56 journal Hepatology 56 SPIRIT III 56 Early Childhood Longitudinal Study 56 CT colonography 56 Localized Prostate Cancer 56 Prospective Randomized Trial 56 Contrast Agent 56 SUCCEED trial 56 Neurologic Disorders 56 RESOLUTE clinical 56 #F FDG PET CT 56 axillary dissection 56 Combination REOLYSIN R 56 CoQ# supplementation 56 double blinded placebo 56 multivariate analyzes 56 denosumab oncology clinical trials 56 Prostate Cancer Patients 56 Folfox 56 hydroxyvitamin D levels 56 cancer mCRC 56 multivariate Cox 56 Skin sterol 56 Fine needle aspiration 56 UKPDS 56 Depressed bipolar 56 Vertos II 56 transient elastography 56 Normative Aging Study 56 Oncotype DX ® 56 SilverHawk Plaque Excision System 56 canakinumab 56 indicates cardio circulatory 56 specific antigen PSA 56 meta analysis pooling 56 colorectal neoplasia 56 refractory metastatic 56 nonpregnant women 56 Nephrology Dialysis Transplantation 56 Francesca Bravi 56 ASPS statistics 56 Aflibercept 56 ANN INTERN MED 56 modified REGENESIS Phase IIb 56 Computed tomography 56 J Clin Oncol 56 transcranial Doppler ultrasound 56 PROSTASCINT 56 abacavir Ziagen 56 Tumor Response 56 dose escalation clinical 56 neoplasias 56 Cancer Institute www.cancer.gov 56 #-# Full Text 56 urine cytology 56 potentially cancerous polyps 56 conjugated equine estrogen 56 Coronary Revascularization 56 Non Alcoholic Steatohepatitis 56 AIR CF2 56 GBA mutations 56 GRN# 56 gadolinium enhanced 56 SCIg 56 radioimmunotherapy RIT 56 axitinib 56 Getzenberg 56 postmenopausal hormone replacement 56 randomized controlled clinical trials 56 fundus photography 56 Estradiol 56 Preclinical Study 56 Atherosclerosis Risk 56 perimenopausal women 56 NABTT 56 TAXUS Liberte Stent 56 chronic prostatitis 56 secretin 56 Mammography Screening 56 sorafenib tablets 56 basal bolus regimen 56 tomosynthesis 56 Li Fraumeni 56 journal Arteriosclerosis Thrombosis 56 inadequately substantiated 56 tramiprosate Alzhemed TM 56 Randomized Double Blind 56 arthrography 56 PET positron emission tomography 56 ductal adenocarcinoma 56 preoperative staging 56 HeFT 56 Catheterization 56 venlafaxine Effexor 56 SEISMIC Trial 56 Acute Stroke 56 nonmelanoma skin cancers 56 Optical Coherence Tomography 56 GAMMAGARD 56 Vaccine Protects Against 56 TIMI Study Group 56 Sodickson 56 lymphomas leukemias 56 VICTOR E1 56 Stent Thrombosis 56 FDG PET CT 56 inflammatory biomarkers 56 EP #R 56 regorafenib 56 ID NCT# 56 prospectively defined 56 Tyrima 56 preterm newborns 56 PREVU * LT 56 preoperative chemotherapy 56 unresectable tumors 56 DXA scan 56 Novartis Zometa 56 fluoroscopy guided 56 Multivariate logistic regression 56 SPECT CT imaging 56 guaiac 56 INSPIRE Trial Phase III 56 Zemiva imaging 56 maternal serum 56 Molecular Breast 56 NCCTG 56 journal Psychological Bulletin 56 NovoTTF 56 test FOBT 56 Rosuvastatin JUPITER 56 renal artery stenosis 56 PD2i ® 55 amalgam fillings mercury vapor 55 multigene expression test 55 Polyp Prevention Trial 55 Hexvix 55 Practice Patterns 55 sputum specimens 55 Medicsight ColonCAD 55 premenopausal 55 digital rectal examination 55 MRI positron emission 55 neoadjuvant 55 pharmacokinetic PK study 55 Claudia Henschke 55 CLARITY study 55 cutaneous melanoma 55 Lung Screening 55 STICH trial 55 Degarelix 55 NeuroImage 55 MGUS 55 citalopram Celexa 55 PreCISe 55 NeuroStar TMS Therapy 55 biochemical relapse 55 MIST II 55 neoadjuvant therapy 55 ACCORD Eye 55 dbGaP 55 assn.org 55 Femara letrozole 55 Cohort Study MACS 55 detect precancerous lesions 55 oesophageal adenocarcinoma 55 CP CPPS